LPL Financial’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $809K | Buy |
306,503
+111,357
| +57% | +$294K | ﹤0.01% | 3901 |
|
|
2025
Q1 | $587K | Sell |
195,146
-62,303
| -24% | -$188K | ﹤0.01% | 3970 |
|
|
2024
Q4 | $659K | Buy |
257,449
+103,495
| +67% | +$265K | ﹤0.01% | 3804 |
|
|
2024
Q3 | $573K | Buy |
153,954
+33,552
| +28% | +$125K | ﹤0.01% | 3821 |
|
|
2024
Q2 | $761K | Buy |
120,402
+59,727
| +98% | +$377K | ﹤0.01% | 3456 |
|
|
2024
Q1 | $326K | Buy |
60,675
+18,002
| +42% | +$96.7K | ﹤0.01% | 4072 |
|
|
2023
Q4 | $214K | Buy |
42,673
+29,756
| +230% | +$149K | ﹤0.01% | 4285 |
|
|
2023
Q3 | $21.8K | Buy |
+12,917
| New | +$21.8K | ﹤0.01% | 4542 |
|
|
2021
Q2 | – | Sell |
-64,205
| Closed | -$1.52M | – | 4232 |
|
|
2021
Q1 | $1.52M | Buy |
+64,205
| New | +$1.52M | ﹤0.01% | 2040 |
|